Click here: to donate by Credit Card
Or here: to donate by PayPal
Or by mail to: Free Republic, LLC - PO Box 9771 - Fresno, CA 93794
Thank you very much and God bless you.
Posted on 08/01/2025 11:42:42 AM PDT by nickcarraway
Meta-analysis assessed trials of SSRIs, esketamine, and psilocybin
Key Takeaways:
-In a comparison of depression treatment trials, control group outcomes in trials of psilocybin were lower than those in trials of SSRIs and esketamine.
-This may suggest that psilocybin's antidepressant efficacy has been overestimated compared with other depression treatment options.
-This could be due to a nocebo effect in the control arms of psilocybin trials, a study author said.
Control group outcomes in randomized trials of psilocybin indicated less improvement in depression scores compared with trials of other antidepressants, according to a meta-analysis, suggesting that psilocybin's efficacy may be lower than previously estimated.
Among 17 trials that tested psilocybin, esketamine (Spravato), or selective serotonin reuptake inhibitors (SSRIs) for depression, standardized mean changes in symptoms measured by the Montgomery-Åsberg Depression Rating Scale (MADRS) from pre- to post-treatment were 1.21 for psilocybin, 1.28 for SSRIs, and 1.43 for esketamine versus 0.50, 1.00, and 1.12 for their respective controls, reported Fredrik Hieronymus, MD, PhD, of the University of Gothenburg in Sweden, and colleagues.
MADRS response rates for control treatments in SSRI and esketamine trials were 14 and 23 percentage points higher, respectively, compared with psilocybin trials, they wrote in JAMA Network Openopens in a new tab or window.
Notably, effect sizes in control treatment arms in psilocybin trials (0.50) were closer to those in waiting-list control (0.37) and care-as-usual (0.64) arms in psychotherapy trials than to those in pill-placebo arms in antidepressant trials (1.05), Hieronymus and team pointed out.
"The poor control treatment outcomes in psilocybin trials suggest that it may not be as broadly effective for depression as estimated," they explained. "The poor performance of control treatments in psilocybin trials is likely caused by 1 of 2 factors: psilocybin trials have recruited patients who are unlikely to respond to control treatment or the psilocybin trialing process applied is less likely to induce control treatment response."
"In other words, assuming that the observed differences are not explained by chance, psilocybin trials must systematically differ from trials of SSRIs and esketamine either in the patient makeup or in some relevant methodologic aspect," they added.
But Hieronymus told MedPage Today that this didn't come as much of a surprise. "There have been reports of poor control group outcomes in psilocybin trials for a while and it's well known that poor control group efficacy can be an issue in depression trials -- for example, in wait-list-controlled psychotherapy trials."
While the meta-analysis confirms the reports of "lower-than-expected control group response rates," it can't explain why this occurs, he noted.
"One intuitive hypothesis is that study participants are able to determine with high certainty when they have not been given a psychoactive dose of psilocybin and that this results in a nocebo effect in the control arms, but the data do not allow us to distinguish that from other possible explanations," he said. "Irrespective of why control group outcomes are worse in psilocybin trials, it's almost certainly a problem. Treatment effects are typically reported and interpreted relative to control groups. For that to be meaningful, the same control treatments, e.g., an inert placebo, needs to work similarly across trials of different compounds.
Psilocybin, found in Psilocybe mushrooms and commonly known as "magic mushrooms," has gained popularity in recent years for psychiatric conditions. However, it's not yet FDA approved for any indications.
For the meta-analysis, the researchers used two prior meta-analyses and an FDA review published between March 2019 and December 2024 to find trials on adult major depressive disorder or treatment-resistant depression. The analysis included four trials on psilocybin (n=373), two on esketamine (n=573), and 11 on SSRIs (n=4,014).
The four psilocybin trials included a phase IIb trial from 2022opens in a new tab or window, a phase II trial from 2023opens in a new tab or window, a phase II trial from 2021opens in a new tab or window, and a phase II trial from 2022opens in a new tab or window.
Time from baseline to evaluation was 6 weeks for nearly all trials, besides two 4-week trials of esketamine and one 2-week evaluation of psilocybin.
During the trials, dropout rates were lower for psilocybin (5% of active arms, 11% of controls) and esketamine (12% of active arms, 8% of controls) trials compared with trials of SSRIs (32% of active arms, 35% of controls).
Study population emerged as a significant moderator of between-group effect sizes (P=0.005) and of pre- to post-control treatment effect sizes (P=0.005), but not of active treatment effect sizes (P=0.55).
"Future studies should strive toward better understanding of which factors moderate control treatment outcomes in psilocybin trials, such as by trialing multiple control treatments and/or by recruiting study participants with positive expectations
|
|
Click here: to donate by Credit Card Or here: to donate by PayPal Or by mail to: Free Republic, LLC - PO Box 9771 - Fresno, CA 93794 Thank you very much and God bless you. |
Here it comes. Can’t have the pharmaceutical industry lose the narrative that only their supposed anti-depressants can help you, instead of something that grows naturally.
yeah, unfortunately, once something gets the reputation of being a street drug then there’s really no science devoted to it anymore. I think I’ve heard that more people have been helped with opium then with any pain reliever in human history but people don’t like to talk about it.
BINGO!
Belladonna grows naturally and has medical properties. Also if it is not harvested or prepared just right it can also kill you.
Nutmeg is natural, really tasty and, in the right amount which is much less then you would think, can also kill you.
All I am saying is be careful before you take anything that is not prepared by a professional. Whether it is a doctor or an herbalist.
Nutmeg?
Sunshine while you can get it on your skin, Vitamin D3 suppement when the weather is cold and one is covered up. The only effective medicine for clinical and manic Deưression.
and certainly don’t forget Hemlock weed and any part of the beautiful oleander shrub ...
I don’t think so.
Yes, it is overstated. Go spend a month hiking our wilderness.
In small amounts, makes food yummy, higher amounts can send you on a trip I have been told is most unpleasant and in even higher amounts can kill you.
In fact a number of the spices in your cabinet can do a number on you if taken in high enough doses. And I do not mean in the "Cinnamon challenge" way.
Plants are very interesting.
One of our old neighbors put too much nutmeg in her coffee or something one time, and basically had a low-grade acid trip.
But you can't make a great pumpkin pie without a little.
I have seen it work in numerous po₫eople including my daughter.Manic Depression is not uncommon in the city in Việt Nam where girls aare taught from birth to never let the sun touch their skin lest then can never get a husband. Igot one young lady out of that 20 years ago and she has proselytized sunshine to all the depressedw omen she has known with 100% success. For them it is 11 months of sunshine and a month to 6 weeks of no visible sun during during rainy season. That is when they get sad depressed again. D3 is not available to them so I send a supply to each family I know primarily to prevent flu/colds during rainy season but for the two I know who suffer depression in that time, too.
Do the research. Search Vitamin D and depressioin and/or Vitamin d and virus. Depression sources are harder to find because there only a few researchers and praticing MDs that have made those findings. itamin D3 is sunshine in a wee gelcap.It has kept me virus free for almost 30 years.
It’s very interesting data.
Not conclusive, but interesting.
Lions Mane works well on my spinal cord injuries. Good stuff!
Correct. Find out if big pharma did these “studies” to discredit something growing in the wild that has helped people.
A little nutmeg goes a long way.
Shades of LSD. The shrinks keep doing this. Announce wonder drug. People use it and start killing each other and going nuts. Drug now tightly controlled and dropped from use . New wonder drug discovered.... Etc etc etc.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.